These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35912746)

  • 21. Diagnostic and prognostic performance of CSF α-synuclein in prion disease in the context of rapidly progressive dementia.
    Mastrangelo A; Baiardi S; Zenesini C; Poleggi A; Mammana A; Polischi B; Ladogana A; Capellari S; Parchi P
    Alzheimers Dement (Amst); 2021; 13(1):e12214. PubMed ID: 34222611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease.
    Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Calero O; Stehmann C; Sarros S; Moda F; Ferrer I; Poleggi A; Pocchiari M; Catania M; Klotz S; O'Regan C; Brett F; Heffernan J; Ladogana A; Collins SJ; Calero M; Kovacs GG; Zerr I
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32059611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High diagnostic performance of plasma and cerebrospinal fluid beta-synuclein for sporadic Creutzfeldt-Jakob disease.
    Abu-Rumeileh S; Halbgebauer S; Bentivenga GM; Barba L; Baiardi S; Mastrangelo A; Oeckl P; Steinacker P; Mammana A; Capellari S; Otto M; Parchi P
    Ann Clin Transl Neurol; 2023 Oct; 10(10):1904-1909. PubMed ID: 37553789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid.
    Orrú CD; Groveman BR; Hughson AG; Zanusso G; Coulthart MB; Caughey B
    mBio; 2015 Jan; 6(1):. PubMed ID: 25604790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered Prion protein expression pattern in CSF as a biomarker for Creutzfeldt-Jakob disease.
    Torres M; Cartier L; Matamala JM; Hernández N; Woehlbier U; Hetz C
    PLoS One; 2012; 7(4):e36159. PubMed ID: 22558368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy.
    Mastrangelo A; Mammana A; Baiardi S; Tiple D; Colaizzo E; Rossi M; Vaianella L; Polischi B; Equestre M; Poleggi A; Capellari S; Ladogana A; Parchi P
    J Neurol Neurosurg Psychiatry; 2023 Feb; 94(2):121-129. PubMed ID: 36428087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Clinical Features, Diagnostic Tests, and Biomarkers in Patients With Suspected Creutzfeldt-Jakob Disease, 2014-2021.
    Shir D; Lazar EB; Graff-Radford J; Aksamit AJ; Cutsforth-Gregory JK; Jones DT; Botha H; Ramanan VK; Prusinski C; Porter A; Day GS
    JAMA Netw Open; 2022 Aug; 5(8):e2225098. PubMed ID: 35921110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis.
    Chang BK; Day GS; Graff-Radford J; McKeon A; Flanagan EP; Algeciras-Schimnich A; Mielke MM; Nguyen A; Jones DT; Toledano M; Kremers WK; Knopman DS; Petersen RC; Li W
    Eur J Neurol; 2022 Oct; 29(10):2905-2912. PubMed ID: 35735602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry.
    Skillbäck T; Rosén C; Asztely F; Mattsson N; Blennow K; Zetterberg H
    JAMA Neurol; 2014 Apr; 71(4):476-83. PubMed ID: 24566866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood β-Synuclein and Neurofilament Light Chain During the Course of Prion Disease.
    Halbgebauer S; Abu-Rumeileh S; Oeckl P; Steinacker P; Roselli F; Wiesner D; Mammana A; Beekes M; Kortazar-Zubizarreta I; Perez de Nanclares G; Capellari S; Giese A; Castilla J; Ludolph AC; Žáková D; Parchi P; Otto M
    Neurology; 2022 Apr; 98(14):e1434-e1445. PubMed ID: 35110380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CSF Ubiquitin Levels Are Higher in Alzheimer's Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease.
    Abu-Rumeileh S; Oeckl P; Baiardi S; Halbgebauer S; Steinacker P; Capellari S; Otto M; Parchi P
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32218217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
    Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P
    J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.
    Gao L; Tang H; Nie K; Wang L; Zhao J; Gan R; Huang J; Zhu R; Feng S; Duan Z; Zhang Y; Wang L
    Int J Neurosci; 2015; 125(9):645-54. PubMed ID: 25202803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of cerebrospinal fluid biomarkers for the differential diagnosis of sporadic Creutzfeldt-Jakob disease: a (network) meta-analysis.
    Rübsamen N; Pape S; Konigorski S; Zapf A; Rücker G; Karch A
    Eur J Neurol; 2022 May; 29(5):1366-1376. PubMed ID: 35075751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease.
    Kanata E; Golanska E; Villar-Piqué A; Karsanidou A; Dafou D; Xanthopoulos K; Schmitz M; Ferrer I; Karch A; Sikorska B; Liberski PP; Sklaviadis T; Zerr I; Llorens F
    J Clin Neurosci; 2019 Feb; 60():124-127. PubMed ID: 30309804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal Fluid Levels of 14-3-3 Gamma: What Does It Tell Us About Sporadic Creutzfeldt-Jakob Disease?
    Humpel C; Benke T
    Pharmacology; 2017; 100(5-6):243-245. PubMed ID: 28743115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt-Jakob Disease Surveillance Network.
    McKenzie N; Piconi G; Culeux A; Hammarin AL; Stergiou C; Tzartos S; Versleijen AAM; van de Geer J; Cras P; Cardone F; Ladogana A; Mannana A; Rossi M; Bongianni M; Perra D; Regelsberger G; Klotz S; Hornemann S; Aguzzi A; Schmitz M; Andrews M; Burns K; Haïk S; Ruiz-García R; Verner-Carlsson J; Tzartos J; Verbeek MM; De Vil B; Poleggi A; Parchi P; Zanusso G; Gelpi E; Frontzek K; Reimann R; Hermann P; Zerr I; Pal S; Green A
    Eur J Neurol; 2022 Aug; 29(8):2431-2438. PubMed ID: 35524506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of Korean patients with suspected Creutzfeldt-Jakob disease with 14-3-3 protein in cerebrospinal fluid: Preliminary study of the Korean Creutzfeldt-Jakob disease active surveillance program.
    Lim JS; Kwon HM; Jang JW; Ju YR; Kim S; Park YH; Park SY; Kim S
    Prion; 2015; 9(2):136-43. PubMed ID: 25996401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creutzfeldt-jakob, Parkinson, lewy body dementia and Alzheimer diseases: from diagnosis to therapy.
    Dupiereux I; Zorzi W; Quadrio I; Perret-Liaudet A; Kovacs GG; Heinen E; Elmoualij B
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):2-11. PubMed ID: 20021333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies.
    Bongianni M; Ladogana A; Capaldi S; Klotz S; Baiardi S; Cagnin A; Perra D; Fiorini M; Poleggi A; Legname G; Cattaruzza T; Janes F; Tabaton M; Ghetti B; Monaco S; Kovacs GG; Parchi P; Pocchiari M; Zanusso G
    Ann Clin Transl Neurol; 2019 Oct; 6(10):2120-2126. PubMed ID: 31599499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.